Benzarone Market Size, Share, Trends and Forecasts to 2015

Benzarone Market Current Trends, Size, Share, Industry Analysis,

Competitive Intelligence, Growth, Opportunities and Forecasts To 2015

Benzarone is the chemical compound also known as Fagivil, Fragivix and Benzarona. Its

chemical formula is C17_H14_O3 and its molecular weight is 265. Chemical name of benzarone

is 2-etyl-3-benzofuranyl p-hydroxyphenyl ketone (WHO).

New techniques and methods for production of benzorane are introduced with increasing demand

in the industry. Benzarone is the cause of chronic active hepatitis. Benzarone stimulates the

incorporation of [14C] - acetate and [3H} - palmitate into cellular lipids. The receptor mediated

uptake of homologous low density lipoproteins. Relative amount of unconjugated glucornidated

and sulphated benzarone were 6, 12 and 82% for both urine and plasma respectively.

Therapeutic Categories:

•

Agent for antivaricose therapy

•

Vasoprotective agent

Major regions operating in worldwide benzarone industry are Latin America, Europe, North

America and Europe. Manufacturers in the regions understand the right requirement for

consumers. The market in projected to drive the benzarone industry demand in the region.

Read Complete Report with TOC: http://www.radiantinsights.com/research/global-andchinese-benzarone-industry-2015-market-research-report

According to laboratory data and liver histology in 1986, diagnosis of subfulminant hepatitis is

due to benzarone administration. Benzarone hepatoxicity mechanism remains unidentified.

Hepatitis is mainly associated with serum anti-smooth muscle antibodies and is preceded by

fever. Hypothesis of an immunoallergic mechanism are mainly favored by these findings. Also,

amiiodarone and benzarone similarities and another derivative for benzofuran indicate the

possibility of common mechanism of hepatoxicity.

Table Of Content:

Chapter One Introduction of Benzarone Industry

1.1 Brief Introduction of Benzarone

1.2 Development of Benzarone Industry

1.3 Status of...